This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eoh, H.
Right arrow Articles by Crick, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eoh, H.
Right arrow Articles by Crick, D. C.

 Previous Article  |  Next Article 

Journal of Bacteriology, December 2007, p. 8922-8927, Vol. 189, No. 24
0021-9193/07/$08.00+0     doi:10.1128/JB.00925-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Characterization of the Mycobacterium tuberculosis 4-Diphosphocytidyl-2-C-Methyl-D-Erythritol Synthase: Potential for Drug Development{triangledown}

Hyungjin Eoh,1 Amanda C. Brown,2 Lori Buetow,3 William N. Hunter,3 Tanya Parish,2 Devinder Kaur,1 Patrick J. Brennan,1 and Dean C. Crick1*

Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523,1 Centre for Infectious Disease, Institute for Cell and Molecular Science, Barts and the London NHS Trust, 4 Newark Street, London E1 2AT, United Kingdom,2 Division of Biological Chemistry and Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, United Kingdom3

Received 12 June 2007/ Accepted 28 September 2007

Mycobacterium tuberculosis utilizes the methylerythritol phosphate (MEP) pathway for biosynthesis of isopentenyl diphosphate and its isomer, dimethylallyl diphosphate, precursors of all isoprenoid compounds. This pathway is of interest as a source of new drug targets, as it is absent from humans and disruption of the responsible genes has shown a lethal phenotype for Escherichia coli. In the MEP pathway, 4-diphosphocytidyl-2-C-methyl-D-erythritol is formed from 2-C-methyl-D-erythritol 4-phosphate (MEP) and CTP in a reaction catalyzed by a 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (IspD). In the present work, we demonstrate that Rv3582c is essential for M. tuberculosis: Rv3582c has been cloned and expressed, and the encoded protein has been purified. The purified M. tuberculosis IspD protein was capable of catalyzing the formation of 4-diphosphocytidyl-2-C-methyl-D-erythritol in the presence of MEP and CTP. The enzyme was active over a broad pH range (pH 6.0 to 9.0), with peak activity at pH 8.0. The activity was absolutely dependent upon divalent cations, with 20 mM Mg2+ being optimal, and replacement of CTP with other nucleotide 5'-triphosphates did not support activity. Under the conditions tested, M. tuberculosis IspD had Km values of 58.5 µM for MEP and 53.2 µM for CTP. Calculated kcat and kcat/Km values were 0.72 min–1 and 12.3 mM–1 min–1 for MEP and 1.0 min–1 and 18.8 mM–1 min–1 for CTP, respectively.

* Corresponding author. Mailing address: Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523. Phone: (970) 491-3308. Fax: (970) 491-1815. E-mail: Dean.Crick{at}colostate.edu

{triangledown} Published ahead of print on 5 October 2007.

Journal of Bacteriology, December 2007, p. 8922-8927, Vol. 189, No. 24
0021-9193/07/$08.00+0     doi:10.1128/JB.00925-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»